Home
About Us
AdAlta at a glance
Board
Management Team
World Class Scientific Advisors
Technology
i-bodies
The i-body platform
Scientific Publications
Pipeline
The Growing AdAlta Pipeline
Fibrosis
CAR-T cancer therapeutics
Investors
Annual and Financial Reports
Presentations
Analyst Reports
ASX Announcements
News & Media
Corporate Governance
Contact Us
AdAlta IPO to Accelerate New Therapy for Lung Fibrosis
August 24, 2016
Archives
2018
..
2017
..
2016
..
2015
..
2014
..
2013
..
2012
..
2011
..